| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1990PNAS...87.8950G |
| P356 | DOI | 10.1073/PNAS.87.22.8950 |
| P8608 | Fatcat ID | release_q6rbewczgfh7jnmscpmbunkmqi |
| P932 | PMC publication ID | 55078 |
| P698 | PubMed publication ID | 2174168 |
| P5875 | ResearchGate publication ID | 20982224 |
| P50 | author | Khandan Keyomarsi | Q50286546 |
| P2093 | author name string | A B Pardee | |
| J Bryan | |||
| A I Geller | |||
| P2860 | cites work | Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor | Q24561804 |
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAs | Q28283363 | ||
| Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos | Q33880924 | ||
| Transformation of mammalian cells with genes from procaryotes and eucaryotes | Q34030262 | ||
| Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer | Q34585324 | ||
| Transcriptional induction of the ubiquitin gene during herpes simplex virus infection is dependent upon the viral immediate-early protein ICP4 | Q34707951 | ||
| Regulation of Simian Virus 40 Transcription: Sensitive Analysis of the RNA Species Present Early in Infections by Virus or Viral DNA | Q36500705 | ||
| Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. | Q36853238 | ||
| Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase | Q37689072 | ||
| Progress toward human gene therapy | Q38646431 | ||
| Biology of gliomas: heterogeneity, oncogenes, growth factors. | Q39499939 | ||
| Molecular Biology of Learning: Modulation of Transmitter Release | Q40131317 | ||
| Palindrome and palindrome-like sequences of herpes simplex virus DNA | Q40155496 | ||
| A new method to propagate defective HSV-1 vectors | Q40547095 | ||
| Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. | Q40560359 | ||
| 53 Long-term culture of dissociated sympathetic neurons | Q41460125 | ||
| A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture | Q41726497 | ||
| Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus | Q42798600 | ||
| A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons | Q43244050 | ||
| Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression | Q43839045 | ||
| Expression of an immediate early polypeptide and activation of a viral origin of DNA replication in cells containing a fragment of herpes simplex virus DNA. | Q44362217 | ||
| Determination of the Sequence Alteration in the DNA of the Herpes Simplex Virus Type 1 Temperature-sensitive Mutant ts K | Q45796540 | ||
| Morphological and physiological studies on cultured nerve cells from guinea pigs infected with herpes simplex virus in vivo | Q45798801 | ||
| Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. | Q45835577 | ||
| The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. | Q45840831 | ||
| Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells | Q45884214 | ||
| Protein kinase C injection into hippocampal pyramidal cells elicits features of long term potentiation | Q59064768 | ||
| Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells | Q67286615 | ||
| Transgenic mice | Q70082646 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| vector-borne disease | Q2083837 | ||
| gene therapy | Q213901 | ||
| P304 | page(s) | 8950-8954 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology | |
| P478 | volume | 87 |
| Q35873295 | A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo |
| Q45887965 | A method to codetect introduced genes and their products in gene therapy protocols |
| Q36256746 | Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene |
| Q36969336 | An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells |
| Q39580097 | An enhanced packaging system for helper-dependent herpes simplex virus vectors |
| Q41526877 | Anti-oncogene Ribozymes for Cancer Gene Therapy |
| Q43934769 | Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir |
| Q38804605 | Construction of recombinant pseudorabies viruses by using PRV BACs deficient in IE180 or pac sequences: Application of vBAC90D recombinant virus to production of PRV amplicons. |
| Q41526891 | Cytokine Gene Transduction in the Immunotherapy of Cancer |
| Q39879535 | Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors |
| Q45746815 | Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo |
| Q33767313 | Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. |
| Q34750374 | Emerging new therapies for chemotherapy-resistant cancer using adenoviral vectors |
| Q44668527 | Enhancement of neuronal protection from oxidative stress by glutamic acid decarboxylase delivery with a defective herpes simplex virus vector |
| Q36851040 | Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia |
| Q40811145 | Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers |
| Q34119491 | Gene therapy for Parkinson's disease: review and update |
| Q45888620 | Gene therapy for leukemia and lymphoma |
| Q33651647 | Genetic analysis of the role of protein kinase C signaling pathways in behaviors by direct gene transfer with HSV-1 vectors |
| Q36897379 | HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. |
| Q58995392 | HSV-1 as a Model for Emerging Gene Delivery Vehicles |
| Q36288901 | HSV-1-based amplicon vectors: design and applications |
| Q33995752 | HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications |
| Q37528088 | HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review |
| Q34534285 | Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors |
| Q35870965 | Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. |
| Q39923388 | Herpes Virus Amplicon Vectors |
| Q35575304 | Herpes simplex virion entry into and intracellular transport within mammalian cells |
| Q36438502 | Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity. |
| Q28288318 | Herpes simplex virus as a transneuronal tracer |
| Q40395117 | Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia |
| Q30834934 | Herpes simplex virus-mediated expression of the axonal protein tau in human model neurons (NT2-N cells). |
| Q40651244 | Human cancer and gene therapy |
| Q37392882 | Immune responses to herpesviral vectors |
| Q45467028 | In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors |
| Q40525981 | Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy |
| Q43154712 | Interventional genetics and cancer treatment |
| Q45880758 | Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures |
| Q43185222 | Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase |
| Q42280576 | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain |
| Q36480190 | Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector |
| Q48455595 | Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. |
| Q28204174 | Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins |
| Q35563389 | Molecular biology and gene therapy in the treatment of chronic pain. |
| Q57847200 | Neoadjuvant Interleukin-12 Immunogene Therapy Protects Against Cancer Recurrence After Liver Resection in an Animal Model |
| Q40329807 | Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector |
| Q35613495 | Oncolytic herpes viruses as a potential mechanism for cancer therapy. |
| Q35210840 | Oral Virus Infections: The Potential for Gene Transfer in Treatment and Prevention |
| Q40728180 | Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. |
| Q37363640 | Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon |
| Q35216652 | Problems in the use of herpes simplex virus as a vector |
| Q33799437 | Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry |
| Q37350126 | The application of viral vectors to enhance regeneration after peripheral nerve repair. |
| Q36150489 | Versatility of gene therapy vectors through viruses |
| Q41235446 | Viral vectors for modulating gene expression in neurons |
| Q34836871 | Virus-based gene delivery systems |
| Q44548784 | p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. |
Search more.